PayPal scammers adopt Docusign API to con customers, electronic employee monitoring reaches an all-time high and Reddit is a ...

Microsoft announced two new AI agents for sales that double as a competitive response to Salesforce in an area where both ...

Salesforce, Inc. is on the right track to grow its Data Cloud and AI-related businesses. Click here to find out why CRM stock ...

Elon Musk has been pressing hard to halt OpenAI’s transition into a for-profit entity. But the high-stakes legal battle isn’t ...

In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against the other stocks. Billionaires and top hedge fund managers dominate the market with large ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We recently published a list of 10 AI Stocks Taking Wall Street by Storm. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOG) stands against other AI stocks taking Wall ...

Need a refill on your contact lenses? We've rounded up the top places to order contacts online that offer competitive pricing, fast shipping and reliable service. Buying your contact lenses online ...

MOSCOW, Feb 19 (Reuters) - Russia is planning to hold high-level contacts with Syria in the near future, Foreign Minister Sergei Lavrov said on Wednesday. President Vladimir Putin spoke by phone ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.

AbbVie said on Monday that it will pay up to $2.2 billion to develop Danish drugmaker Gubra's experimental obesity drug, marking its late foray into the segment. Under the terms of the deal, the ...